BioSpace News Archive

Cardiac Catheterization Market: Increase in number of angiographic procedures to drive the market

Cardiac catheterization can be defined as a procedure to test the functioning of the heart and is used to diagnose and treat cardiovascular conditions.

August 27, 2021
·
6 min read
Therapeutic Support Surface Demand to Soar through 2031, Sales of Bariatric Beds will Increase Amidst Surging Prevalence of Obesity

Fact.MR – A Market Research and Competitive Intelligence Provider: A recent report on the therapeutic support surface market by Fact.MR predicts that the market will register a CAGR of 6.2% during the forecast period of 2021 to 2031.

August 27, 2021
·
7 min read
Drug Development

AlzeCure’s ACD856 Demonstrates Good Tolerability in Phase I Clinical Trial and is Approved for Additional Doses

AlzeCure Pharma AB announced that the company has received approval from the Medical Products Agency to be able to give additional doses of ACD856 in the clinical phase I study with ACD856, as its good tolerability enables higher doses to be tested

August 27, 2021
·
6 min read
TILT Biotherapeutics Reports Publication on its Oncolytic Immunotherapy Platform in Pancreatic Cancer

TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapeutics, announces that new preclinical data relating to the use of its oncolytic immunotherapy platform for expressing a human IL-2 variant protein has been published in Frontiers in Immunology.

August 27, 2021
·
4 min read
Biotech Beach

Axonics® to Participate in Upcoming Investor Conferences - Aug 27, 2021

Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, announced that senior management will present at the following virtual investor conferences

August 27, 2021
·
1 min read
Drug Development

ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002

ImmunoBrain Checkpoint Inc. announced that the National Institute on Aging of the US National Institutes of Health has awarded the Company a grant totaling $5 million over three years to support a first-in-human clinical study of IBC-Ab002, for the treatment of Alzheimer’s disease.

August 27, 2021
·
6 min read
Policy

Health Canada approval of low-dose colchicine for cardiovascular disease based on the COLCOT study

People with coronary disease now have a new treatment option to reduce the risk of cardiovascular events.

August 27, 2021
·
5 min read
Clinical Trial Supply and Logistics Market: Geographical Outlook & Competitive Landscape 2018 - 2026

The report details an exhaustive account of the global clinical trial supply and logistics market along with numerous associated factors.

August 27, 2021
·
6 min read
Business

Nordic Nanovector ASA: Results for the Second Quarter and First Half 2021

Nordic Nanovector ASA announces its results for the second quarter and first half 2021.

August 27, 2021
·
7 min read
Deals

BICO has acquired Advanced BioMatrix, an innovative company focused on 3D applications, to, together, ensure a market leading portfolio of bioinks and reagents

BICO, the leading Bio Convergence company, has acquired all outstanding shares in Advanced BioMatrix Corp. (Advanced BioMatrix), an American company focusing on 3D research applications.

August 27, 2021
·
4 min read